Related Experiment Video

Updated: May 15, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Treatment of HBV related cirrhosis

Florian van Bömmel1, Thomas Berg

  • 1Sektion Hepatologie, Klinik für Gastroenterologie und Rheumatologie, Universitätsklinikum Leipzig, Liebigstr, Germany.

Liver International : Official Journal of the International Association for the Study of the Liver
|January 5, 2013
PubMed

Insights

Hepatitis B virus (HBV)-associated cirrhosis, once considered irreversible, can now be reversed. Effective treatment and risk factor management are crucial for managing HBV cirrhosis and preventing complications like liver cancer.

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Background:

  • Hepatitis B virus (HBV)-associated cirrhosis traditionally viewed as irreversible.
  • Cirrhosis significantly increases mortality and hepatocellular carcinoma (HCC) risk.
  • High incidence of HCC in cirrhotic patients compared to non-cirrhotic HBV patients and asymptomatic carriers.

Purpose of the Study:

  • To highlight the shift in understanding HBV-associated cirrhosis from irreversible to potentially reversible.
  • To emphasize the importance of effective treatment for HBV cirrhosis.
  • To underscore the need for identifying and avoiding risk factors for cirrhosis and hepatic decompensation.

Main Methods:

  • Review of recent findings on HBV replication suppression and liver fibrosis reversal.
  • Analysis of HCC incidence rates in different HBV infection stages.
  • Discussion of treatment strategies for HBV-related cirrhosis.

Main Results:

  • Long-term suppression of HBV replication can reverse high-grade liver fibrosis.
  • Liver transplantation was previously the primary intervention for severe HBV cirrhosis.
  • Effective management strategies are emerging for HBV-associated liver disease.

Conclusions:

  • HBV-associated cirrhosis is no longer considered an irreversible condition.
  • Effective antiviral therapy can promote liver regeneration and reverse fibrosis.
  • Comprehensive management including treatment and risk factor avoidance is essential for patients with HBV cirrhosis.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...